Literature DB >> 19135312

The pattern of failure after reirradiation of recurrent squamous cell head and neck cancer: implications for defining the targets.

Aron Popovtzer1, Iris Gluck, Douglas B Chepeha, Theodoros N Teknos, Jeffrey S Moyer, Mark E Prince, Carol R Bradford, Avraham Eisbruch.   

Abstract

PURPOSE: Reirradiation (re-RT) of recurrent head and neck cancer (HNC) may achieve long-term disease control in some patients, at the expense of high rates of late sequelae. Limiting the re-RT targets to the recurrent gross tumor volume (rGTV) would reduce the volumes of reirradiated tissues; however, its effect on tumor recurrence pattern is unknown. METHODS AND MATERIALS: This is a retrospective review of 66 patients who underwent curative-intent re-RT for nonresectable recurrent or second primary mucosal squamous cell HNC. Treatment was delivered with three-dimensional conformal (3D) RT or intensity-modulated RT (IMRT). The targets in all patients consisted of the rGTVs with tight (0.5-cm) margins, with no intent to treat prophylactically lymph nodes or subclinical disease in the vicinity of the rGTVs. The sites of locoregional failures (LRFs) were determined using imaging at the time of failure and were compared with the rGTVs.
RESULTS: Median re-RT dose was 68 Gy. Forty-seven patients (71%) received concomitant chemotherapy, and 31 (47%) received hyperfractionated, accelerated RT. At a median follow-up of 42 months, 16 (23%) were alive and disease-free. Fifty patients (77%) had a third recurrence or persistent disease, including 47 LRFs. All LRFs occurred within the rGTVs except for two (4%) (95% confidence interval, 0-11%). Nineteen patients (29%) had Grade > or = 3 late complications, mostly dysphagia (12 patients).
CONCLUSIONS: Almost all LRFs occurred within the reirradiated rGTVs despite avoiding prophylactic RT of tissue at risk of subclinical disease. These results support confining the re-RT targets to the rGTVs to reduce reirradiated tissue volumes.

Entities:  

Mesh:

Year:  2009        PMID: 19135312      PMCID: PMC2765822          DOI: 10.1016/j.ijrobp.2008.10.042

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  28 in total

1.  Acceleration of hyperfractionated chemoradiation regimen for advanced head and neck cancer.

Authors:  Aaron M Allen; Mohamed Elshaikh; Francis P Worden; Carol R Bradford; Theodoros N Teknos; Douglas B Chepeha; Christina Tsien; Laura A Dawson; Susan Urba; Gregory T Wolf; Daniel Normolle; Avraham Eisbruch
Journal:  Head Neck       Date:  2007-02       Impact factor: 3.147

2.  Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma.

Authors:  Joseph K Salama; Everett E Vokes; Steven J Chmura; Michael T Milano; Johnny Kao; Kirsten M Stenson; Mary Ellyn Witt; Daniel J Haraf
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-10-05       Impact factor: 7.038

3.  Outcomes following reirradiation of patients with head and neck cancer.

Authors:  David P Goldstein; Lucy Hynds Karnell; Min Yao; G Parker Chamberlin; Thanh X Nguyen; Gerry F Funk
Journal:  Head Neck       Date:  2008-06       Impact factor: 3.147

4.  Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies.

Authors:  Noel M Kramer; Eric M Horwitz; Jonathan Cheng; John A Ridge; Steven J Feigenberg; Roger B Cohen; Nicos Nicolaou; Eric J Sherman; James S Babb; Jason A Damsker; Corey J Langer
Journal:  Head Neck       Date:  2005-05       Impact factor: 3.147

5.  Salvage re-irradiation for recurrent head and neck cancer.

Authors:  Nancy Lee; Kelvin Chan; Justin E Bekelman; Joanne Zhung; James Mechalakos; Ashwatha Narayana; Suzanne Wolden; Ennapadam S Venkatraman; David Pfister; Dennis Kraus; Jatin Shah; Michael J Zelefsky
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-03-26       Impact factor: 7.038

6.  Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck.

Authors:  Sharon A Spencer; Jonathan Harris; Richard H Wheeler; Mitchell Machtay; Christopher Schultz; William Spanos; Marvin Rotman; Ruby Meredith; Kie-Kian Ang
Journal:  Head Neck       Date:  2008-03       Impact factor: 3.147

7.  Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer.

Authors:  Matthew C Biagioli; Mark Harvey; Eloy Roman; Luis E Raez; Aaron H Wolfson; Subhakar Mutyala; Hyo S Han; Arnold Markoe
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-11-15       Impact factor: 7.038

8.  Results of postoperative reirradiation for recurrent or second primary head and neck carcinoma.

Authors:  Nicolien Kasperts; Ben J Slotman; C Rene Leemans; Remco de Bree; Patricia Doornaert; Johannes A Langendijk
Journal:  Cancer       Date:  2006-04-01       Impact factor: 6.860

9.  Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911.

Authors:  Corey J Langer; Jonathan Harris; Eric M Horwitz; Nicos Nicolaou; Merrill Kies; Walter Curran; Stuart Wong; Kian Ang
Journal:  J Clin Oncol       Date:  2007-10-20       Impact factor: 44.544

10.  IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.

Authors:  Erik P Sulman; David L Schwartz; Thuy T Le; K Kian Ang; William H Morrison; David I Rosenthal; Anesa Ahamad; Merril Kies; Bonnie Glisson; Randal Weber; Adam S Garden
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-06-14       Impact factor: 7.038

View more
  28 in total

1.  Hyperfractionated stereotactic reirradiation for recurrent head and neck cancer.

Authors:  Jakub Cvek; Lukas Knybel; Eva Skacelikova; Jiri Stransky; Petr Matousek; Karol Zelenik; Oldrich Res; Bretislav Otahal; Lukas Molenda; David Feltl
Journal:  Strahlenther Onkol       Date:  2015-08-28       Impact factor: 3.621

Review 2.  Reirradiation of Skull Base Tumors With Advanced Highly Conformal Techniques.

Authors:  Jennifer C Ho; Jack Phan
Journal:  Curr Oncol Rep       Date:  2017-10-28       Impact factor: 5.075

3.  Hyperfractionation compared to standard fractionation in intensity-modulated radiation therapy for patients with locally advanced recurrent nasopharyngeal carcinoma.

Authors:  Victor H F Lee; Dora L W Kwong; To-Wai Leung; Sherry C Y Ng; Ka-On Lam; Chi-Chung Tong; Chun-Kin Sze
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-10-13       Impact factor: 2.503

4.  Reirradiation with IMRT for recurrent head and neck cancer: A single-institutional report on disease control, survival, and toxicity.

Authors:  Parveen Ahlawat; Sheh Rawat; Anjali Kakria; Bharti Devnani; Inderjit Kaur Wahi; David K Simson
Journal:  Rep Pract Oncol Radiother       Date:  2017-06-07

5.  Outcome after re-irradiation of head and neck cancer patients.

Authors:  Nele Platteaux; Piet Dirix; Bianca Vanstraelen; Sandra Nuyts
Journal:  Strahlenther Onkol       Date:  2010-12-22       Impact factor: 3.621

6.  IMRT reirradiation with concurrent cetuximab immunotherapy in recurrent head and neck cancer.

Authors:  Felix Zwicker; Falk Roeder; Christian Thieke; Carmen Timke; Marc W Münter; Peter E Huber; Jürgen Debus
Journal:  Strahlenther Onkol       Date:  2010-12-23       Impact factor: 3.621

7.  Coronaric stent-graft deployment in the treatment of carotid blowout.

Authors:  E Pampana; R Gandini; M Stefanini; S Fabiano; A Chiaravalloti; D Morosetti; S Spano; G Simonetti
Journal:  Interv Neuroradiol       Date:  2011-12-16       Impact factor: 1.610

8.  Clinical challenges in the implementation of a tomotherapy service for head and neck cancer patients in a regional UK radiotherapy centre.

Authors:  S Chatterjee; J H Mott; G Smyth; S Dickson; W Dobrowsky; C G Kelly
Journal:  Br J Radiol       Date:  2010-12-15       Impact factor: 3.039

9.  A nomogram to predict loco-regional control after re-irradiation for head and neck cancer.

Authors:  Nadeem Riaz; Julian C Hong; Eric J Sherman; Luc Morris; Matthew Fury; Ian Ganly; Tony J C Wang; Weji Shi; Suzanne L Wolden; Andrew Jackson; Richard J Wong; Zhigang Zhang; Shyam D Rao; Nancy Y Lee
Journal:  Radiother Oncol       Date:  2014-06-30       Impact factor: 6.280

10.  Reirradiation to the abdomen for gastrointestinal malignancies.

Authors:  Waqar Haque; Christopher H Crane; Sunil Krishnan; Marc E Delclos; Milind Javle; Christopher R Garrett; Robert A Wolff; Prajnan Das
Journal:  Radiat Oncol       Date:  2009-11-18       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.